SCANCELL

Welcome to the Brand page for “SCANCELL”, which is offered here for Pharmaceutical preparations, for the treatment of cancer; therapeutic preparations and substances, for the treatment of cancer; chemical preparations, for the treatment of cancer; diagnostic reagents for medical use; dna, antibodies and proteins that stimulate high-avidity t-cells responses for therapeutic and medical use, for the treatment of cancer; pharmaceutical compounds for treatment of cancer; vaccine preparations and substances; peptide vaccines; dna vaccines and substances; therapeutic preparations and substances for medical use, dna, antibodies and proteins for use in expressing epitopes, for use in encoding, for use in vectoring to target cells, and for use in stimulating cells; vaccines, including dna vaccines; therapeutic preparations for use in t-cell therapy and chimeric antigen receptor t-cell therapy to treat cancer;pharmaceutical testing and clinical trials for others; provision of information and consultancy in relation to the aforesaid services; scientific and technological services, research and design in the field of drug development for the treatment of cancer; pharmaceutical research and development services; research and development in the biotechnology field; provision of information and consultancy in relation to the aforesaid services;.

Its status is currently believed to be active. Its class is unavailable. “SCANCELL” is believed to be currently owned by “Scancell Limited”.